✦ LIBER ✦

Tamoxifen (Nolvadex) for premenopausal patients with advanced breast cancer

✍ Scribed by R. Margreiter; J. Wiegele

Publisher: Springer US
Year: 1984
Tongue: English
Weight: 376 KB
Volume: 4
Category: Article
ISSN: 0167-6806
DOI: 10.1007/bf01806987

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined endocrine effects of LHRH agoni

Combined endocrine effects of LHRH agonist (Zoladex®) and tamoxifen (Nolvadex®) therapy in premenopausal women with breast cancer

✍ Mr J. F. R. Robertson; K. J. Walker; R. I. Nicholson; R. W. Blamey 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB 👁 2 views

Abstract In premenopausal women with breast cancer, the use of the luteinizing hormone releasing hormone agonist, goserelin, results in the production of serum levels of oestradiol equivalent to those after surgical oöphorectomy or in postmenopausal women. The standard first line hormonal treatment

Tamoxifen (Nolvadex) therapy — Radionale

Tamoxifen (Nolvadex) therapy — Radionale for loading dose followed by maintenance dose for patients with metastatic breast cancer

✍ P. M. Wilkinson; G. G. Ribiero; H. K. Adam; J. V. Kemp; J. S. Patterson 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 243 KB

Chemoimmunotherapy with or without oopho

Chemoimmunotherapy with or without oophorectomy in premenopausal patients with advanced breast cancer

✍ Hwee-Yong Yap; Gabriel N. Hortobagyi; George R. Blumenschein; Charles K. Tashima 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

Ninety-eight premenopausal patients with stage IV breast cancer were treated with chemoimmunotherapy alone, or with combination oophorectomy-chemoimmunotherapy either simultaneously (chemoimmunotherapy within four weeks of oophorectomy) or sequentially (delayed chemoimmunotherapy until evidence of p

Meakin adjuvant regimen in premenopausal

Meakin adjuvant regimen in premenopausal patients with breast cancer

✍ D. Smith; J. A. Dewar; J. M. Horobin; J. S. Scott; Mr P. E. Preece 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB

Chemohormonal therapy for advanced breas

Chemohormonal therapy for advanced breast cancer with tamoxifen, adriamycin, and cyclophosphamide (TAC)

✍ Frederick R. Ahmann; Stephen E. Jones; Thomas E. Moon; Neel Hammond; Thomas P. M 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 639 KB

Combined chemohormonal therapy is an attractive therapeutic strategy for the treatment of Stage IV breast cancer. Between 1977 and 1979, the authors evaluated a new chemohormonal therapy program in 63 evaluable women with advanced breast cancer who previously had not received cytotoxic chemotherapy

Treatment of advanced breast cancer with

Treatment of advanced breast cancer with aminoglutethimide after therapy with tamoxifen

✍ Aman U. Buzdar; Kimberly C. Powell; Sewa S. Legha; George R. Blumenschein 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 2 views